Vice President of Clinical Integrations and Improvement
Obstetrics & Gynecology
Dr. Julian C. Schink, MD
|
|
Give Review
Julian Schink works in the field of Obstetrics & Gynecology. He attended University of Texas Medical School. He over the years received 3 awards: "Meaningful Use Stage 1 Certification", "Super Doctor" and "Fellow (FACOG)". Julian Schink is a published physician. He has 81 papers published. The most current publication "Methotrexate sequestration in an ovarian cyst." He is registered with Medicare.
Publications
- Content validity of the NCCN-FACT Ovarian Symptom Index-18 (NFOSI-18).
- Bringing PROMIS to practice: Brief and precise symptom screening in ambulatory cancer care.
- Biomarker Testing for Breast, Lung, and Gastroesophageal Cancers at NCI Designated Cancer Centers.
- Improving Diversity in Cancer Research Trials: The Story of the Cancer Disparities Research Network.
- Is dexamethasone associated with recurrence of ovarian cancer?
- Human Ovarian Tissue Cortex Surrounding Benign and Malignant Lesions.
- Ovarian cancer, version 2.2013.
- Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: Results of a Phase 2 Trial of the Gynecologic Oncology Group.
- Evaluation of Outcomes in Patients With Carcinoma of the Cervix Treated With Concurrent Radiation and Cisplatin Versus Cisplatin/5-FU Compared With Radiation Alone.
- The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian cancer.
- Cost of cancer: there is more to it than containing chemotherapy costs.
- Dosimetry and toxicity outcomes in postoperative high-dose-rate intracavitary brachytherapy for endometrial carcinoma.
- Exfoliative cytology of primary poorly differentiated (small-cell) neuroendocrine carcinoma of the uterine cervix in ThinPrep material: a case report.
- Liquid-based cytologic specimen studies to screen for cervical dysplasia in rural El Salvador.
- Phase 1 trial of intraperitoneal AD-32 in gynecologic malignancies.
- Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalan.
- The genetics of ovarian cancer: concepts in testing and counseling.
- The time has come for the medical management of ectopic pregnancy.
- DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
- Progesterone Receptor-B Induction of BIRC3 Protects Endometrial Cancer Cells from AP1-59-Mediated Apoptosis.
- Malignant melanoma of the vulva: an extension of cutaneous melanoma?
- Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after prima...
- PET/CT in gynecologic cancer: present applications and future prospects--a clinician's perspective.
- Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.
- Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors.
- Point: chemosensitivity assays have a role in the management of recurrent ovarian cancer.
- Epithelial ovarian cancer.
- Management of metastatic high-risk gestational trophoblastic neoplasia: FIGO stages II-IV: risk factor score > or = 7.
- "Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases".
- A prospective trial comparing lymphangiogram, cross-sectional imaging, and positron emission tomography scan in the detection of lymph node metastasis in locally advan...
- The impact of robotics on practice management of endometrial cancer: transitioning from traditional surgery.
- Robotic surgery in gynecologic oncology: impact on fellowship training.
- FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
- An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
- Absence of progesterone receptors in a failed case of fertility-sparing treatment in early endometrial cancer: a case report.
- Ovarian cancer. Clinical practice guidelines in oncology.
- Results of treatment of patients with gestational trophoblastic neoplasia referred to the Brewer Trophoblastic Disease Center after failure of treatment elsewhere (197...
- Gestational trophoblastic neoplasia: treatment outcomes.
- Perinucleolar compartment prevalence is a phenotypic pancancer marker of malignancy.
- Sonohysterography and endometrial cancer: incidence and functional viability of disseminated malignant cells.
- Chemosensitization of endometrial cancer cells through AKT inhibition involves FOXO1.
- The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma.
- Weekly topotecan for recurrent platinum resistant ovarian cancer.
- Weekly docetaxel and carboplatin for recurrent ovarian and peritoneal cancer: a phase II trial.
- Cancer of the cervix: current management and new approaches.
- Role of surgery in the management of high-risk gestational trophoblastic neoplasia.
- Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
- Lymphoepithelioma-like carcinoma of the vulva: a case report.
- Saline contrast sonohysterography and directed extraction, resection and biopsy of intrauterine pathology using a Uterine Explora Curette.
- Long-term complications associated with the Indiana pouch urinary diversion in patients with recurrent gynecologic cancers after high-dose radiation.
- Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53.
- Topotecan is an active agent in the first-line treatment of metastatic or recurrent endometrial carcinoma: Eastern Cooperative Oncology Group Study E3E93.
- Progress of a Comprehensive Familial Cancer Genetic Counseling Program in the Era of BRCA1 and BRCA2.
- A phase II trial of daily perillyl alcohol in patients with advanced ovarian cancer: Eastern Cooperative Oncology Group Study E2E96.
- A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer.
- Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: an Eastern Cooperative O...
- High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
- Paclitaxel, carboplatin, and hexamethyl-melamine (taxchex) as first-line therapy for ovarian cancer.
- Familial ovarian germ cell cancer: report and review.
- Managing the care of patients with advanced ovarian cancer.
- Current initial therapy of stage III and IV ovarian cancer: challenges for managed care.
- Methotrexate sequestration in an ovarian cyst.
- Resection of a giant aggressive angiomyxoma in the Philippines.
- Infiltrating ductal carcinoma of the vulva.
- Problems in the culture diagnosis of gonorrhea.
- Tumor size in endometrial cancer: a prognostic factor for lymph node metastasis.
- Laser vaporization versus laser excision conization in the treatment of cervical intraepithelial neoplasia.
- Synergistic effect of combined intraperitoneal cisplatin and cytosine arabinoside in a murine ovarian cancer model.
- Prognostic significance of positive peritoneal cytology in clinical stage I adenocarcinoma of the endometrium.
- Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium.
- Tumor size in endometrial cancer.
- A phase I-II trial of intraperitoneal cisplatin and alpha-interferon in patients with persistent epithelial ovarian cancer.
- Nintendo enuresis.
- Ovarian carcinoma metastatic to the breast and axillary node.
- An elevated maternal serum alpha-fetoprotein leading to the diagnosis of an immature teratoma.
- Endometrial stromal sarcoma with rhabdoid differentiation.
- Microinvasive cervix cancer.
- Rare gynecologic malignancies.
- A two-step approach to the treatment of invasive vulvar cancer in pregnancy.
- Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
Schools
University of Texas Medical School At San Antonio
Northwestern Mem Hospital
Doctors Specialties
- Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACOG)
Education
-
UCLA Medical Center -
McGaw Medical Center of Northwestern University -
University of Texas Medical School
Hospital
-
Northwestern Memorial Hospital -
Lurie Children's Hospital of Chicago
Helpful Reviews
Similar Doctors
|
|
Dr. Somboon Sriaroon, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Albert Chams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lauren F. Streicher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Narendra Karmali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Serdar E. Bulun, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Leanne R. Griffin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin S. Balin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manuel M. Escalona Jr., MD |
|
|
Dr. Clare B. Harney, MD
This Doctor is OpenDoctor Recommended.
|